All Posts Tagged With: "GlaxoSmithKline"
February 12th, 2016 - By Gary James
Britain’s watchdog for competition had fined pharmaceutical giant GlaxoSmithKline £37.5 million or $54.4 million due to market abuse. The watchdog said GSK entered into deals that called for the delay of launching inexpensive generic copies of Seroxat its former antidepressant blockbuster. The generic drug companies that were involved, including Merck based in Germany, were fined […]